Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot study

Atrial fibrillation (AF) is linked to cardiomyocyte apoptosis, leading to atrial remodelling and reduction in electrical conduction velocity. We hypothesized that genetic suppression of an apoptotic key enzyme, caspase 3, would prevent the development of persistent AF by reducing apoptosis which may...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Trappe, Kerstin (VerfasserIn) , Thomas, Dierk (VerfasserIn) , Bikou, Olympia (VerfasserIn) , Kelemen, Kamilla (VerfasserIn) , Lugenbiel, Patrick (VerfasserIn) , Voss, Frederik (VerfasserIn) , Becker, Rüdiger (VerfasserIn) , Katus, Hugo (VerfasserIn) , Bauer, Alexander (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2013
In: European heart journal
Year: 2013, Jahrgang: 34, Heft: 2, Pages: 147-157
ISSN:1522-9645
DOI:10.1093/eurheartj/ehr269
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/eurheartj/ehr269
Volltext
Verfasserangaben:Kerstin Trappe, Dierk Thomas, Olympia Bikou, Kamilla Kelemen, Patrick Lugenbiel, Frederik Voss, Rüdiger Becker, Hugo A. Katus, and Alexander Bauer

MARC

LEADER 00000caa a2200000 c 4500
001 178921212X
003 DE-627
005 20220820125202.0
007 cr uuu---uuuuu
008 220210s2013 xx |||||o 00| ||eng c
024 7 |a 10.1093/eurheartj/ehr269  |2 doi 
035 |a (DE-627)178921212X 
035 |a (DE-599)KXP178921212X 
035 |a (OCoLC)1341441466 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Trappe, Kerstin  |d 1981-  |e VerfasserIn  |0 (DE-588)14081616X  |0 (DE-627)622582240  |0 (DE-576)320910229  |4 aut 
245 1 0 |a Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3  |b a pre-clinical pilot study  |c Kerstin Trappe, Dierk Thomas, Olympia Bikou, Kamilla Kelemen, Patrick Lugenbiel, Frederik Voss, Rüdiger Becker, Hugo A. Katus, and Alexander Bauer 
246 3 0 |a three 
264 1 |c 2013 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online publish-ahead-of-print 23 July 2011 
500 |a Gesehen am 10.02.2022 
520 |a Atrial fibrillation (AF) is linked to cardiomyocyte apoptosis, leading to atrial remodelling and reduction in electrical conduction velocity. We hypothesized that genetic suppression of an apoptotic key enzyme, caspase 3, would prevent the development of persistent AF by reducing apoptosis which may serve as an arrhythmogenic substrate.Atrial fibrillation was induced in domestic pigs by atrial burst pacing via an implanted cardiac pacemaker. Study animals were then assigned to receive either Ad-siRNA-Cas3 gene therapy to inactivate caspase 3 or green fluorescent protein (Ad-GFP) as a control. Adenoviruses were applied using a hybrid technique employing right and left atrial virus injection followed by epicardial electroporation to increase expression of plasmid DNA. In pigs treated with Ad-siRNA-Cas3, the onset of AF was suppressed or significantly delayed compared with controls (10.3 ± 1.2 days vs. 6.0 ± 1.6 days; P= 0.04). Electrical mapping revealed prolonged atrial conduction in the control group that was prevented by Ad-siRNA-Cas3 gene therapy. On the molecular level, Ad-siRNA-Cas3 application resulted in down-regulation of caspase 3 expression and suppression of apoptotic activity.Knockdown of caspase 3 by atrial Ad-siRNA-Cas3 gene transfer suppresses or delays the onset of persistent AF by reduction in apoptosis and prevention of intra-atrial conduction delay in a porcine model. These results highlight the significance of apoptosis in the pathophysiology of AF and demonstrate short-term efficacy of gene therapy for suppression of AF. 
700 1 |a Thomas, Dierk  |d 1974-  |e VerfasserIn  |0 (DE-588)123896258  |0 (DE-627)706465601  |0 (DE-576)29393164X  |4 aut 
700 1 |a Bikou, Olympia  |e VerfasserIn  |0 (DE-588)1024753360  |0 (DE-627)720453569  |0 (DE-576)36944096X  |4 aut 
700 1 |a Kelemen, Kamilla  |d 1976-  |e VerfasserIn  |0 (DE-588)129031933  |0 (DE-627)387884386  |0 (DE-576)29745742X  |4 aut 
700 1 |a Lugenbiel, Patrick  |d 1982-  |e VerfasserIn  |0 (DE-588)137855710  |0 (DE-627)696120062  |0 (DE-576)305349414  |4 aut 
700 1 |a Voss, Frederik  |d 1968-  |e VerfasserIn  |0 (DE-588)122527364  |0 (DE-627)705940152  |0 (DE-576)293308845  |4 aut 
700 1 |a Becker, Rüdiger  |e VerfasserIn  |0 (DE-588)1032502541  |0 (DE-627)738501409  |0 (DE-576)380071061  |4 aut 
700 1 |a Katus, Hugo  |d 1951-  |e VerfasserIn  |0 (DE-588)108916618  |0 (DE-627)577155040  |0 (DE-576)289625076  |4 aut 
700 1 |a Bauer, Alexander  |d 1966-  |e VerfasserIn  |0 (DE-588)115589082  |0 (DE-627)691434549  |0 (DE-576)289965233  |4 aut 
773 0 8 |i Enthalten in  |t European heart journal  |d Oxford : Oxford University Press, 1980  |g 34(2013), 2, Seite 147-157  |h Online-Ressource  |w (DE-627)320415813  |w (DE-600)2001908-7  |w (DE-576)103746846  |x 1522-9645  |7 nnas  |a Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3 a pre-clinical pilot study 
773 1 8 |g volume:34  |g year:2013  |g number:2  |g pages:147-157  |g extent:11  |a Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3 a pre-clinical pilot study 
856 4 0 |u https://doi.org/10.1093/eurheartj/ehr269  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220210 
993 |a Article 
994 |a 2013 
998 |g 115589082  |a Bauer, Alexander  |m 115589082:Bauer, Alexander  |d 50000  |e 50000PB115589082  |k 0/50000/  |p 9  |y j 
998 |g 108916618  |a Katus, Hugo  |m 108916618:Katus, Hugo  |d 910000  |d 910100  |e 910000PK108916618  |e 910100PK108916618  |k 0/910000/  |k 1/910000/910100/  |p 8 
998 |g 1032502541  |a Becker, Rüdiger  |m 1032502541:Becker, Rüdiger  |d 50000  |e 50000PB1032502541  |k 0/50000/  |p 7 
998 |g 122527364  |a Voss, Frederik  |m 122527364:Voss, Frederik  |d 50000  |e 50000PV122527364  |k 0/50000/  |p 6 
998 |g 137855710  |a Lugenbiel, Patrick  |m 137855710:Lugenbiel, Patrick  |d 910000  |d 910100  |e 910000PL137855710  |e 910100PL137855710  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 129031933  |a Kelemen, Kamilla  |m 129031933:Kelemen, Kamilla  |d 50000  |e 50000PK129031933  |k 0/50000/  |p 4 
998 |g 1024753360  |a Bikou, Olympia  |m 1024753360:Bikou, Olympia  |d 50000  |e 50000PB1024753360  |k 0/50000/  |p 3 
998 |g 123896258  |a Thomas, Dierk  |m 123896258:Thomas, Dierk  |d 910000  |d 910100  |e 910000PT123896258  |e 910100PT123896258  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 14081616X  |a Trappe, Kerstin  |m 14081616X:Trappe, Kerstin  |d 910000  |d 910100  |e 910000PT14081616X  |e 910100PT14081616X  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN178921212X  |e 4055594690 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Kerstin Trappe, Dierk Thomas, Olympia Bikou, Kamilla Kelemen, Patrick Lugenbiel, Frederik Voss, Rüdiger Becker, Hugo A. Katus, and Alexander Bauer"]},"note":["Online publish-ahead-of-print 23 July 2011","Gesehen am 10.02.2022"],"title":[{"title_sort":"Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3","subtitle":"a pre-clinical pilot study","title":"Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3"}],"language":["eng"],"physDesc":[{"extent":"11 S."}],"id":{"eki":["178921212X"],"doi":["10.1093/eurheartj/ehr269"]},"recId":"178921212X","origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"2013"}],"relHost":[{"origin":[{"publisherPlace":"Oxford ; London [u.a.]","dateIssuedKey":"1980","dateIssuedDisp":"1980-","publisher":"Oxford University Press ; Harcourt"}],"id":{"zdb":["2001908-7"],"eki":["320415813"],"issn":["1522-9645"]},"title":[{"title":"European heart journal","title_sort":"European heart journal"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 12.09.2017"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"320415813","part":{"extent":"11","issue":"2","year":"2013","text":"34(2013), 2, Seite 147-157","pages":"147-157","volume":"34"},"disp":"Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3 a pre-clinical pilot studyEuropean heart journal","pubHistory":["1.1980 -"]}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"display":"Trappe, Kerstin","family":"Trappe","role":"aut","given":"Kerstin"},{"role":"aut","display":"Thomas, Dierk","family":"Thomas","given":"Dierk"},{"given":"Olympia","display":"Bikou, Olympia","family":"Bikou","role":"aut"},{"display":"Kelemen, Kamilla","family":"Kelemen","role":"aut","given":"Kamilla"},{"given":"Patrick","role":"aut","display":"Lugenbiel, Patrick","family":"Lugenbiel"},{"given":"Frederik","role":"aut","display":"Voss, Frederik","family":"Voss"},{"given":"Rüdiger","role":"aut","display":"Becker, Rüdiger","family":"Becker"},{"given":"Hugo","role":"aut","display":"Katus, Hugo","family":"Katus"},{"given":"Alexander","role":"aut","display":"Bauer, Alexander","family":"Bauer"}]} 
SRT |a TRAPPEKERSSUPPRESSIO2013